Healthcare & Biotech
-
DeepCure Raises $24M for AI-Driven Drug Discovery
DeepCure secures $24M for AI-driven drug development, aiming to accelerate drug discovery and innovation in immunology and inflammation.
-
Reshape Biotech: $20M Boost to Revolutionize Global R&D!
Reshape Biotech secures $20m in Series A funding, backed by high-profile investors, aims to revolutionize biotech R&D globally.
-
Nucleai’s $14M Boost for AI Healthcare Breakthroughs
Nucleai secures $14M led by M Ventures, fueling AI-driven healthcare innovation for disease detection, treatment, and drug development.
-
UK Startup Boosts AlphaFold’s Protein Folding Accuracy by 6x
Basecamp Research revolutionizes biotech with unique dataset, accelerating drug discovery, challenging Big Tech, and promoting sustainable data sourcing.
-
Fast DEC-DFL: Revolutionizing Public Health with AI
The study accelerates health planning, improves model accuracy, and achieves global health goals by leveraging technology and data.
-
Limbic’s Leap: AI Chatbot’s $14M Boost for Mental Health
London-based Limbic secured $14M in Series A funding, led by Khosla Ventures, to expand its AI mental health chatbot to the US. Achieved UKCA Class…
-
CognitiveEMS: Revolutionary AI Assistant Boosts EMS Efficiency
CognitiveEMS offers wearable AI assistance for EMS, with fine-tuned models improving decision-making, reducing cognitive load, and indicating investment potential.
-
AI Revolutionizes Neonatal Risk Assessment!
Machine learning accurately predicts high-risk newborn outcomes, inspiring a user-friendly app for neonatologists to improve intervention planning.
-
Baseimmune’s £9M Milestone Pioneers Mutation-Proof Vaccines
UK biotech Baseimmune secures £9m for predictive vaccine technology, targeting known diseases and future variants in healthcare and biotech.
-
Bioptimus Kickstarts AI Biology Revolution with $35M
Bioptimus secures $35m seed funding for foundational biology model. Aims to impact biotech, collaborate with Owkin, AWS.
Eksentricity 